Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Illumina Inc. is a biotechnology company specializing in the development, manufacture, and marketing of integrated systems for the analysis of genetic variation and function. Primarily, Illumina provides innovative sequencing and array-based solutions that enable unparalleled personalization of health and life sciences applications. These solutions are utilized in a broad spectrum of sectors, including genomics research, oncology, reproductive health, agriculture, and pharmaceutical development. Illumina's technologies are crucial for the advancement of precision medicine, allowing for more effective targeting of therapeutic interventions tailored to individual genetic makeups. The company's products and services serve researchers and healthcare professionals, facilitating deeper insights into complex genetic patterns and enhancing the understanding of biological systems. As a significant player in the genomics industry, Illumina holds a strategic position for the progression of genetic analysis and its integration into various aspects of healthcare and research, supporting advancements in personalized medicine and the life sciences field globally.